Training Course on Normalized Surgery for Hernia and Abdominal Wall Surgery in Beijing Chaoyang Hospital

At present, the company's main business is to obtain SFDA registration in 2005, which is the first domestic product approved for listing. Leaders attach great importance to technological innovation and personnel training, and invest a large amount of money every year in the research and development of new products. Depending on the existing product base, through technical upgrading and technological innovation, the company will complete the product line of soft tissue defect repair with high, medium and low equipment, so that the company's products are not only suitable for general surgery, but also extended to the repair of tissue defects in thoracic surgery and gynecological surgery. To improve the integrity of the product line and gain the overall competitiveness of the market, to achieve the company's strong point in the field of soft tissue repair materials, and to maintain the leading goal.